NeoVanc: Over 50% of patients now enrolled!

04 Sep, 2018

We are delighted to bring you the news that successful randomisation of over 50% of NeoVanc’s target has been achieved. Congratulations to all the NeoVanc team on hitting this momentous milestone and for your on-going hard work and commitment to the trial.picture1 We look forward to continuing to work closely with you in achieving our target of 300 evaluable participants and we wish those sites still to recruit their first participant the best of luck!